Roche stops enrollment in Avastin trial; House probes another J&J-related recall;

@FiercePharma: Who's vulnerable to Amgen's new bone drug? Report | Follow @FiercePharma

> In another setback for Roche's cancer drug Avastin, an independent board recommended that the company stop enrolling patients into a test of the drug against non-Hodgkin's lymphoma because the benefits didn't outweigh its risks. Report

> The House Committee on Oversight and Government Reform asked Blacksmith Brands for information about its recall of PediaCare cough and cold medicines made by Johnson & Johnson at the same plant that produced children's Tylenol and other recalled kids drugs. Report

> Astellas Pharma said it had wrapped up its initial tender offer for shares in OSI Pharmaceuticals, coming one step closer to finishing the $4 billion all-cash deal. Report

> The U.K.'s cost-effectiveness watchdog recommended use of thalidomide against multiple myeloma, providing a boost to Celgene, the U.S. company that has commercialized for new uses of the drug once notorious for causing birth defects. Report

> Teva Pharmaceutical Industries said that, contrary to Israeli media reports, it still expects to post revenue of about $16 billion in 2010. Report

> Indian drugmaker Ranbaxy expects $100 million in revenue from its South African operations in 2010, the firm's chief executive said. Report

Biotech News

 @FierceBiotech: Report: Pharma cuts 6,943 jobs in May. Article | Follow @FierceBiotech

 @JohnCFierce: Two months ahead of schedule, FDA approves D-mab. Article | Follow @JohnCFierce

> Sanofi R&D chief eager to strike new deals on eye drugs. Item

> FDA panel rejects AZ's new RSV drug in key setback. Story

Vaccines News

> Breast cancer vaccine success stirs controversy. Report

> Brain cancer vax promising in PhI. News

Manufacturing News

> Blacksmith recalls drugs made at Tylenol plant. Report

> Demand for offshore drug manufacturing could improve quality. Story

> Claris antibiotics recalled due to mold contamination. News

> Security layers needed to protect drug supply chain. Report

And Finally... Elite and pro athletes using drugs to enhance performance is nothing new. But poker players? Report